Company news
GT Biopharma, Inc. news in 2022
GT Biopharma, Inc.'s news releases, calls and decks from 2022, newest first.
GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering Priced At Premium To Market
December 29, 2022
GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer
December 13, 2022
GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
November 9, 2022
GT Biopharma to Present New Data on Novel Dual-Antigen Targeting Approach Against AML at Upcoming 2022 ASH Annual Meeting
November 2, 2022
GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update
October 30, 2022
GT Biopharma Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
October 5, 2022
GT Biopharma Announces Adjournment of Special Shareholders Meeting
October 3, 2022
GT Biopharma Affirms Manufacturing Timeline For Lead Investigational Asset GTB-3650
August 29, 2022
GT Biopharma Reports Second Quarter Fiscal 2022 Financial Results and Business Update
August 10, 2022
GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress
June 9, 2022
GT Biopharma Reports First Quarter Fiscal 2022 Financial Results and Business Update
May 15, 2022
GT Biopharma Presents Preclinical Data Demonstrating Novel B7H3+ Tumor Targeting GTB-5550 TriKE® Driving NK Cell Activation and ADCC Against Head and Neck Squamous Cell Carcinomas at AACR Annual Meeting 2022
April 10, 2022
GT Biopharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
March 27, 2022
GT Biopharma Presents TriKE® Nanobody Pipeline (GTB-5550) Preclinical Multiple Myeloma Proof-of-Concept Data at 2022 EBMT Annual Meeting
March 20, 2022
GT Biopharma to Present Pre-Clinical Data at Upcoming Medical Conferences
February 23, 2022
GT Biopharma Appoints Manu Ohri as Chief Financial Officer
February 17, 2022
GT Biopharma Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2022